芒果视频下载

成立于1998年，知名阿膠品牌，以藥業/酒業為主導，集研發/生產/經營/投資/管理于一體的綜合性集團公司，產品涵蓋了中西藥制劑/生物制藥/原料藥/保健食品等品類

1998年成立的輔仁藥業集團，是一家以藥業、酒業為主導，集研發、生產、經營、投資、管理于一體的綜合性集團公司。集團(tuan)囊括河(he)(he)南(nan)輔(fu)(fu)仁(ren)堂(tang)制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)輔(fu)(fu)仁(ren)懷(huai)慶堂(tang)制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、開封(feng)制藥(yao)(yao)(yao)(yao)（集團(tuan)）有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、開封(feng)豫(yu)港制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、開藥(yao)(yao)(yao)(yao)集團(tuan)（開魯）制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)同源(yuan)制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)醫(yi)藥(yao)(yao)(yao)(yao)科(ke)技開發(fa)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)(yao)業集團(tuan)醫(yi)藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)(yao)業集團(tuan)熙德隆腫瘤藥(yao)(yao)(yao)(yao)品有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、北(bei)京遠策藥(yao)(yao)(yao)(yao)業有(you)(you)(you)限(xian)(xian)(xian)(xian)責任(ren)公(gong)(gong)(gong)(gong)(gong)司(si)、北(bei)京輔(fu)(fu)仁(ren)瑞輝生物醫(yi)藥(yao)(yao)(yao)(yao)研究院、上海輔(fu)(fu)仁(ren)醫(yi)藥(yao)(yao)(yao)(yao)研發(fa)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、鄭州遠策生物制藥(yao)(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、河(he)(he)南(nan)省宋河(he)(he)酒業股份有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)及上市公(gong)(gong)(gong)(gong)(gong)司(si)輔(fu)(fu)仁(ren)藥(yao)(yao)(yao)(yao)業集團(tuan)制藥(yao)(yao)(yao)(yao)股份有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)等(deng)多家全(quan)資、控股子公(gong)(gong)(gong)(gong)(gong)司(si)。

集(ji)(ji)團產(chan)品涵蓋了中西藥(yao)制(zhi)劑、生物制(zhi)藥(yao)、原(yuan)料藥(yao)、保(bao)健食(shi)品等多個門類(lei)。2006年，隨著河南輔(fu)(fu)仁(ren)(ren)堂制(zhi)藥(yao)有(you)限公司成功(gong)實現上市，資(zi)(zi)本的力量不僅把(ba)輔(fu)(fu)仁(ren)(ren)推向(xiang)一個飛速發展時期，其(qi)行業地位亦逐步提(ti)升。2017年12月29日，輔(fu)(fu)仁(ren)(ren)藥(yao)業重大資(zi)(zi)產(chan)重組成功(gong)，把(ba)集(ji)(ji)團優質資(zi)(zi)產(chan)——開封制(zhi)藥(yao)（集(ji)(ji)團）有(you)限公司置入輔(fu)(fu)仁(ren)(ren)藥(yao)業，使輔(fu)(fu)仁(ren)(ren)藥(yao)業跨入一個新的發展階段。

“品(pin)種為(wei)(wei)核心(xin)，并購為(wei)(wei)主線”的(de)(de)早(zao)期發展戰略讓輔(fu)(fu)仁藥(yao)業集團的(de)(de)產能和產品(pin)線在很短時間內飛速發展。迄(qi)今(jin)，輔(fu)(fu)仁藥(yao)業集團已擁有(you)水(shui)針劑(ji)、凍干粉(fen)針劑(ji)、口(kou)服固(gu)體(ti)制(zhi)劑(ji)等20多(duo)個(ge)(ge)劑(ji)型(xing)，1000余(yu)個(ge)(ge)品(pin)種；制(zhi)劑(ji)綜合產能位居全國制(zhi)藥(yao)行業前茅。2017新版(ban)(ban)醫保目(mu)錄(lu)輔(fu)(fu)仁藥(yao)業集團共入選578個(ge)(ge)品(pin)種，較2009版(ban)(ban)目(mu)錄(lu)增(zeng)加品(pin)種165個(ge)(ge)，增(zeng)幅(fu)(fu)39.95%，其中甲類(lei)入選364個(ge)(ge)，增(zeng)幅(fu)(fu)42.754%，乙(yi)類(lei)入選214個(ge)(ge)，增(zeng)幅(fu)(fu)35.44%。在國家衛(wei)健委正式發布(bu)《國家基本(ben)藥(yao)物目(mu)錄(lu)（2018年版(ban)(ban)）》中，輔(fu)(fu)仁藥(yao)業集團共有(you)阿莫西林克拉維(wei)酸鉀干混懸(xuan)劑(ji)、奧美拉唑腸(chang)溶(rong)膠囊、注射用重組人干擾素α2b等262個(ge)(ge)品(pin)規(gui)榜上(shang)有(you)名，較2012版(ban)(ban)目(mu)錄(lu)增(zeng)加75個(ge)(ge)，增(zeng)幅(fu)(fu)40.11%，成為(wei)(wei)全國入選品(pin)種較多(duo)的(de)(de)制(zhi)藥(yao)企(qi)業之一。

輔仁(ren)藥業(ye)(ye)集(ji)團(tuan)一直遵循“濟世(shi)(shi)藥為輔、惠民(min)志在仁(ren)”的企(qi)業(ye)(ye)理(li)念(nian)，始終貫徹(che)“產量讓(rang)位(wei)于質(zhi)量、成本讓(rang)位(wei)于質(zhi)量”的質(zhi)量管理(li)方針，本著“和而不同、化繁為簡、務實(shi)創新(xin)、濟世(shi)(shi)惠民(min)”的企(qi)業(ye)(ye)價值觀，把“做(zuo)一家(jia)實(shi)體型(xing)、科技(ji)型(xing)、國際型(xing)企(qi)業(ye)(ye)”作為自己的企(qi)業(ye)(ye)定位(wei)，兼容并蓄，尊(zun)重規(gui)律，踐行規(gui)則。

在(zai)企(qi)業(ye)并(bing)購的同(tong)(tong)時(shi)，輔(fu)仁藥業(ye)集(ji)團(tuan)投入巨資加強(qiang)企(qi)業(ye)創新(xin)(xin)平(ping)(ping)臺(tai)(tai)建設，戰略性布局鄭州技術研(yan)(yan)(yan)發(fa)(fa)和國(guo)(guo)際(ji)化合作及產(chan)業(ye)化服(fu)務平(ping)(ping)臺(tai)(tai)、北京創新(xin)(xin)研(yan)(yan)(yan)發(fa)(fa)平(ping)(ping)臺(tai)(tai)、上海醫(yi)藥研(yan)(yan)(yan)發(fa)(fa)創新(xin)(xin)國(guo)(guo)際(ji)合作平(ping)(ping)臺(tai)(tai)、美國(guo)(guo)新(xin)(xin)澤西、費城(cheng)研(yan)(yan)(yan)發(fa)(fa)平(ping)(ping)臺(tai)(tai)四大(da)研(yan)(yan)(yan)發(fa)(fa)創新(xin)(xin)平(ping)(ping)臺(tai)(tai)，以(yi)及中(zhong)醫(yi)藥大(da)數據及人工(gong)智能中(zhong)醫(yi)研(yan)(yan)(yan)發(fa)(fa)平(ping)(ping)臺(tai)(tai)，更將在(zai)小分子化學藥、大(da)分子生物藥研(yan)(yan)(yan)發(fa)(fa)和中(zhong)醫(yi)藥傳承創新(xin)(xin)方向同(tong)(tong)時(shi)發(fa)(fa)力(li)，開辟以(yi)研(yan)(yan)(yan)發(fa)(fa)驅動創新(xin)(xin)的發(fa)(fa)展新(xin)(xin)路徑。

目前，輔(fu)(fu)(fu)仁藥業(ye)集團(tuan)支(zhi)持創新研發(fa)面(mian)積達11.3萬(wan)平(ping)方(fang)米，研發(fa)創新隊(dui)伍近1500人(ren)。同時(shi)，秉承“中(zhong)國市場、輔(fu)(fu)(fu)仁平(ping)臺、全(quan)球(qiu)資源”的發(fa)展策略，輔(fu)(fu)(fu)仁藥業(ye)集團(tuan)實現(xian)了從(cong)“百姓藥、輔(fu)(fu)(fu)仁造(zao)”到“創新藥、輔(fu)(fu)(fu)仁造(zao)”的可持續發(fa)展跨越，為客戶(hu)及整個社會創造(zao)價值，健康中(zhong)國，服務世界。